PRESS RELEASE published on 06/30/2025 at 07:30, 11 months 26 days ago Nicox annonce que le dernier patient a terminé l’essai clinique de Phase 3 Denali sur NCX 470 Nicox annonce la fin de l'essai clinique de Phase 3 Denali sur NCX 470. Premiers résultats attendus entre mi-août et mi-septembre 2025. Autorisation de mise sur le marché aux Etats-Unis prévue pour le premier semestre 2026 Essai Clinique Pharmaceutique Nicox NCX 470 Glaucome
BRIEF published on 06/06/2025 at 07:35, 1 year ago Nicox Announces Shareholders’ Meeting and Ad Hoc Representative Voting Rights Shareholders’ Meeting Euronext Growth Nicox Ad Hoc Representative
BRIEF published on 06/06/2025 at 07:35, 1 year ago Nicox annonce une assemblée générale des actionnaires et un représentant ad hoc Euronext Growth Droit De Vote Assemblée Générale Des Actionnaires Nicox Représentant Ad Hoc
PRESS RELEASE published on 06/06/2025 at 07:30, 1 year ago Nicox: Notice of the Ordinary and Extraordinary Shareholders’ Meeting on June 27, 2025 and appointment of an ad hoc representative Nicox SA announces Ordinary and Extraordinary Shareholders' Meeting on June 27, 2025, appoints ad hoc representative. Details on agenda, proxy voting, and meeting participation Shareholders' Meeting Proxy Voting Nicox SA Ad Hoc Representative Meeting Participation
PRESS RELEASE published on 06/06/2025 at 07:30, 1 year ago Nicox : Convocation à l’Assemblée Générale Ordinaire et Extraordinaire le 27 juin 2025 et désignation d’un mandataire ad hoc Nicox convoque une Assemblée Générale Ordinaire et Extraordinaire le 27 juin 2025, avec un mandataire ad hoc pour représenter les actionnaires défaillants Actionnaires Assemblée Générale Ophtalmologie Nicox Mandataire Ad Hoc
BRIEF published on 05/27/2025 at 07:35, 1 year ago Nicox obtient jusqu'à 3 millions d'euros grâce à Kowa pour l'avancée de NCX 470 Phase 3 Nicox Hypertension Oculaire NCX 470 Kowa
BRIEF published on 05/27/2025 at 07:35, 1 year ago Nicox secures up to €3 million from Kowa to advance NCX 470 Ocular Hypertension Phase 3 Nicox NCX 470 Kowa
PRESS RELEASE published on 05/27/2025 at 07:30, 1 year ago Nicox annonce jusqu’à 3 millions d’euros de paiements d’étapes de la part de Kowa en 2025, alors que NCX 470 se prépare à entrer en essais cliniques de Phase 3 au Japon Nicox annonce jusqu’à 3 millions d’euros de paiements d’étapes de la part de Kowa en 2025 pour le lancement d'essais cliniques de Phase 3 de NCX 470 au Japon, prolongeant ainsi leur horizon de trésorerie Essais Cliniques Nicox Horizon De Trésorerie Kowa Paiements D'étapes
BRIEF published on 05/14/2025 at 07:35, 1 year 1 month ago Nicox Reports Findings from Whistler Phase 3b Glaucoma Trial Glaucoma Nicox NCX 470 Whistler Phase 3b Intraocular Pressure
BRIEF published on 05/14/2025 at 07:35, 1 year 1 month ago Nicox publie les résultats de l'essai de phase 3b sur le glaucome à Whistler Nicox NCX 470 Glaucome Whistler Phase 3b Pression Intraoculaire
Published on 06/26/2026 at 01:40, 8 hours 16 minutes ago UraniumX Announces DTC Eligibility for U.S. Traded Shares
Published on 06/25/2026 at 23:30, 10 hours 26 minutes ago Zeus North America Mining Corp. Signs Option Agreement to Acquire Mining Claims in Idaho
Published on 06/25/2026 at 22:30, 11 hours 26 minutes ago Fountain Asset Corp. Provides Corporate Update
Published on 06/25/2026 at 21:32, 12 hours 24 minutes ago BlackBerry Announces Election Results for the Company's Board of Directors
Published on 06/25/2026 at 15:30, 18 hours 26 minutes ago Silver Spruce Resources, Inc. Adds Mining, Energy, and Finance Development Expertise to the Board and Announces Director Resignation
Published on 06/26/2026 at 09:43, 12 minutes ago ABO Energy secures wind energy tariffs and achieves further successes
Published on 06/26/2026 at 09:41, 14 minutes ago Emerald Horizon AG begins trading on the Vienna Stock Exchange
Published on 06/26/2026 at 09:26, 30 minutes ago Hamburg Direct Bank wins two German Brand Awards 2026
Published on 06/26/2026 at 09:25, 30 minutes ago SKYWORTH Solar Shines at Intersolar Europe 2026, Shaping the Future of Energy in Europe with a Comprehensive Product Matrix
Published on 06/26/2026 at 09:19, 36 minutes ago Zero Waste Foundation brought Türkiye’s COP31 vision to Bonn
Published on 06/26/2026 at 07:00, 2 hours 56 minutes ago Advancing Women’s Health with Rapid Diagnostics: bioMérieux files a Dual 510(k) /CLIA Waiver application to the FDA for the BIOFIRE® SPOTFIRE® Vaginitis Panel
Published on 06/26/2026 at 07:00, 2 hours 56 minutes ago Améliorer la santé des femmes grâce au diagnostic rapide : bioMérieux dépose auprès de la FDA une demande combinée d’autorisation 510(k) et de dérogation CLIA pour son test BIOFIRE® SPOTFIRE® Vaginitis Panel
Published on 06/25/2026 at 18:45, 15 hours 10 minutes ago Avis Financier Semestriel SFCMC au 30 avril 2026
Published on 06/25/2026 at 18:30, 15 hours 26 minutes ago Avis financier semestriel SIEHM au 30 avril 2026
Published on 06/25/2026 at 17:50, 16 hours 6 minutes ago DISCLOSURE OF SHARE CAPITAL AND VOTING RIGHTS